InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Linde Peter, Directeur Médical. Insider active across 1 companies, notably Morphic Holding, Inc.. Aggregated, 4 filings have been logged. Total volume traded: €378k. The latest transaction was filed on 1 June 2021 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations4 total
10,378 shares
Common Stock
SEC:0001209191-21-056733·
10,378 shares
Common Stock
SEC:0001209191-21-056733:0·
€189,1514,648 shares@ €40.6951100.0% of flow
Common Stock
SEC:0001209191-21-037927·
€189,1514,648 shares@ €40.695150.0% of flow
Common Stock
SEC:0001209191-21-037927:0·
4 of 4 declarations
About Linde Peter
Peter Linde is the Chief Medical Officer at Morphic Holding, Inc. In this role, he is responsible for the strategic direction of the company's medical initiatives. His expertise contributes to the innovation and enhancement of the treatments offered by Morphic, focusing on research and the development of new therapies. Linde plays a key role in aligning medical objectives with the overall vision of the company.
